Acute Myeloid Leukemia (AML) poses a formidable challenge as a rapidly progressing cancer of the blood and bone marrow. This malignancy affects white blood cells and strikes individuals of various age groups, with a higher incidence observed in those over the age of 55. Despite aggressive treatment approaches involving chemotherapy, radiation therapy, and stem cell transplantation, AML patients face a difficult prognosis, characterized by a low long-term survival rate.
What is Acute Myeloid Leukemia?
Acute Myeloid Leukemia (AML) stands out as a cancer that swiftly infiltrates the blood and bone marrow, impacting the production of normal blood cells. This malignancy predominantly affects the myeloid line of blood cells, including red blood cells, platelets, and various white blood cells. AML progresses rapidly, overwhelming the bone marrow and bloodstream with abnormal, immature cells. The consequences are severe, leading to compromised immune function, anemia, and an increased risk of bleeding.
AML does not discriminate based on age, affecting both children and adults. However, the risk significantly escalates in individuals aged 55 and above. The conventional treatment landscape for AML involves an intensive combination of chemotherapy, radiation therapy, and, in some instances, stem cell transplantation.
Cannabis As a Treatment for Cancer Symptoms
The historical use of cannabis in medicinal contexts spans over 4,000 years, and in recent times, it has garnered attention for its potential role in alleviating cancer symptoms. Cannabis sativa, the plant from which marijuana is derived, boasts more than 400 compounds, with over 60 cannabinoids identified. Of these, tetrahydrocannabinol (THC) and cannabidiol (CBD) have emerged as primary focuses of research, showcasing diverse therapeutic properties.
Recent literature delves into the potential of cannabis and cannabinoids in mitigating the symptoms of cancer and easing the side effects associated with conventional cancer treatments, such as nausea, sleep issues, and diminished appetite. The findings are intriguing, suggesting that cannabinoids may help alleviate various side effects of cancer treatments.
Cannabis As a Complementary Treatment
While it is essential to note that cannabis is not a cure for cancer, several studies suggest that it can be beneficial in managing certain symptoms and side effects associated with cancer and its treatment.
One of the primary reasons cannabis is considered a valuable complementary treatment is its ability to alleviate chemotherapy-induced nausea and vomiting. The active compounds in cannabis, particularly tetrahydrocannabinol (THC) and cannabidiol (CBD), have been shown to interact with the body’s endocannabinoid system, which plays a role in regulating nausea and vomiting. The American Cancer Society acknowledges that some cancer patients find relief from nausea and vomiting by using cannabis.
Moreover, cannabis may help cancer patients manage pain. Both THC and CBD have demonstrated analgesic properties, providing pain relief without the same addictive potential as opioid medications. The National Cancer Institute recognizes that cannabis may be effective in reducing cancer-related pain.
Another potential benefit of cannabis in cancer care is its role in improving appetite. Cancer patients often experience a loss of appetite, leading to weight loss and decreased overall well-being. THC, the psychoactive component of cannabis, has been shown to stimulate appetite, which can be especially beneficial for patients undergoing cancer treatment.
While research on the topic is ongoing, support exists for the idea that cannabis can be a valuable complementary treatment for cancer-related symptoms. It is crucial for patients to consult with their healthcare providers before incorporating cannabis into their treatment plan, considering individual health factors and potential interactions with other medications.
For AML patients grappling with the adverse effects of traditional cancer treatments, such as pain, nausea, and vomiting, cannabis emerges as a complementary therapy offering relief. By reducing inflammation and modulating the immune system, cannabinoids contribute to an enhanced quality of life for AML patients undergoing rigorous treatment regimens.
Get Your Medical Card Today
As the landscape of medical cannabis evolves, obtaining a medical card becomes a crucial step for patients seeking access to this alternative therapy for acute myeloid leukemia. Pause Pain & Wellness is at the forefront, ready to assist individuals in this journey. With clinics strategically located across the state, including Oxford, Meridian, Flowood/Jackson, Tupelo, Olive Branch, Starkville, Hattiesburg, and Gulfport, our dedicated team stands prepared to provide the necessary assistance. Contact us at 833-940-5060 to obtain your medical card. Our knowledgeable and compassionate professionals are here to guide you through the process, ensuring that you can explore the potential benefits of cannabis as a complementary therapy in managing AML symptoms.